相关实验视频

Updated: May 29, 2025

Production of Human CRISPR-Engineered CAR-T Cells

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

用合成受体和CRISPR技术进行血液癌症治疗

Haiying Zhang¹, Mingxin Zhong¹, Jingdong Zhang¹

¹Department of Hematology, Ganzhou People's Hospital, Ganzhou, Jiangxi 341000, China; Jiangxi Health Commission Key Laboratory of Leukemia, Ganzhou, Jiangxi 341000, China.

Leukemia research

|February 7, 2025

概括

本综述探讨了将仿真抗原受体 (CAR) -T/NK细胞与合成受体和CRISPR工具相结合,通过提高疗效和降低毒性来改善血液癌症治疗.

科学领域:

免疫治疗是一种免疫疗法.
分子生物学分子生物学
在瘤学瘤学.

背景情况:

化学抗原受体 (CAR) -T和-NK细胞对血液性恶性瘤有效.
基于CAR的治疗方法的局限性需要先进的方法.
合成受体和CRISPR技术为这些挑战提供了解决方案.

研究的目的:

审查CAR与合成受体 (GPCR,synNotch) 和CRISPR/Cas工具的整合,用于治疗血液癌症.
要突出这些结合策略如何可以提高CAR细胞的功能和持久性.
讨论这些综合疗法的进展,挑战和未来方向.

主要方法:

对基于CAR的疗法,合成受体和CRISPR/Cas系统的当前文献的审查.
对条件瘤杀伤功能和预防免疫逃逸的机制的分析.
讨论CRISPR/Cas工具以提高CAR细胞的性能.

主要成果:

通过将CAR与合成受体集成,可以条件杀死瘤并减少目标外效应.
克里斯普尔/卡斯工具可以显著提高CAR细胞的功能和长期持久性.
结合方法在克服当前CAR疗法的局限性方面表现有前途.

结论:

将CAR技术与合成受体和CRISPR/Cas工具相结合,代表了血液癌症治疗的前沿.
这些综合策略提供了增强的特异性,有效性和安全性.
对进步,陷和未来前景的进一步研究对于临床翻译至关重要.

关键词:

卡尔-NK 是一个卡尔-NK.在CART-T中,我们可以使用CAR-T.克里斯普尔是什么意思?克里斯普尔是什么意思?癌症免疫疗法癌症免疫疗法在GPCR中,GPCR是指GPCR.这就是SynNotch的意义.

更多相关视频

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...